329 related articles for article (PubMed ID: 8299097)
1. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
Mizutani Y; Yoshida O
Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097
[TBL] [Abstract][Full Text] [Related]
2. Overcoming tnf-alpha and cddp resistance of a human ovarian-cancer cell-line (c30) by treatment with buthionine sulfoximine in combination with tnf-alpha and or cddp.
Mizutani Y; Bonavida B
Int J Oncol; 1993 Aug; 3(2):229-35. PubMed ID: 21573353
[TBL] [Abstract][Full Text] [Related]
3. Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
Mizutani Y; Bonavida B
Cancer; 1993 Aug; 72(3):809-18. PubMed ID: 8334635
[TBL] [Abstract][Full Text] [Related]
4. Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
J Urol; 1994 Jun; 151(6):1697-702. PubMed ID: 8189599
[TBL] [Abstract][Full Text] [Related]
5. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Mistry P; Loh SY; Kelland LR; Harrap KR
Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
7. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
[TBL] [Abstract][Full Text] [Related]
8. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
Kang YJ
Toxicology; 1994 Mar; 88(1-3):177-89. PubMed ID: 8160199
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistance.
Safrit JT; Belldegrun A; Bonavida B
J Urol; 1993 May; 149(5):1202-8. PubMed ID: 8483246
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline enhances sensitivity of a human ovarian cancer cell line (OVC-8) to TNF-alpha.
Mizutani Y; Bonavida B
Biotherapy; 1993-1994; 7(2):109-14. PubMed ID: 7803190
[TBL] [Abstract][Full Text] [Related]
11. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
12. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
Lee KS; Kim HK; Moon HS; Hong YS; Kang JH; Kim DJ; Park JG
Korean J Intern Med; 1992 Jul; 7(2):111-7. PubMed ID: 1306072
[TBL] [Abstract][Full Text] [Related]
13. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis.
Yokomizo A; Kohno K; Wada M; Ono M; Morrow CS; Cowan KH; Kuwano M
J Biol Chem; 1995 Aug; 270(33):19451-7. PubMed ID: 7642628
[TBL] [Abstract][Full Text] [Related]
14. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
Bier H
Acta Otolaryngol; 1991; 111(4):797-806. PubMed ID: 1950544
[TBL] [Abstract][Full Text] [Related]
15. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
16. [Augmentation of TNF- and lymphotoxin-mediated cytotoxic effect in the combined use of ACNU and involvement of oxygen free radicals].
Matsunaga K; Mashiba H
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):452-8. PubMed ID: 2321976
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
18. Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages.
Gosset P; Wallaert B; Tonnel AB; Fourneau C
Eur Respir J; 1999 Jul; 14(1):98-105. PubMed ID: 10489835
[TBL] [Abstract][Full Text] [Related]
19. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
Lai GM; Ozols RF; Young RC; Hamilton TC
J Natl Cancer Inst; 1989 Apr; 81(7):535-9. PubMed ID: 2493524
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance.
Safrit JT; Bonavida B
Cancer Res; 1992 Dec; 52(23):6630-7. PubMed ID: 1330298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
